Teitur Trophics

Aarhus, Denmark

Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.

$30.0M raised

Mar 2023

Series A

Biotechnology Life Science Medical

Top Investors

InnovestorSound BioventuresSunstone Life Science VenturesIndustrifondenp53

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Teitur Trophics

How much funding has Teitur Trophics raised?

Teitur Trophics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Who are Teitur Trophics's investors?

Teitur Trophics's investors include Innovestor, Sound Bioventures, Sunstone Life Science Ventures, Industrifonden, p53.

Where is Teitur Trophics headquartered?

Teitur Trophics is headquartered in Aarhus, Denmark.

What does Teitur Trophics do?

Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.

What stage is Teitur Trophics at?

Teitur Trophics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2023.

MLA

"Teitur Trophics — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/teitur-trophics. Accessed June 17, 2026.

APA

VCBacked. (2023). Teitur Trophics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/teitur-trophics

Wikipedia (cite web)

{{cite web |title=Teitur Trophics — Funding & Investors |url=https://www.vcbacked.co/company/teitur-trophics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2023.

Similar Companies in Biotechnology